Dr. Emily Reiser is the Director of Strategy and New Ventures at the Texas Medical Center (TMC), where she contributes to the Texas Medical Center Venture Fund and other strategic projects across TMC. In previous roles at TMC, Emily has spearheaded accelerator programs in cancer therapeutics and healthtech, led the recruitment of entrepreneurs in residence, and supported BioBridge global relationships.
Emily earned her bachelor’s degree in Biology from Emory University and a PhD in Bioengineering from Rice University, where her research focused on drug delivery for cancer immunotherapy.
